A rival of pharmaceutical giant Merck Sharp and Dohme (MSD) is trying to sell a generic version of a cholesterol drug for less than one tenth of the price of its product in breach of patent rights, it has been claimed in court proceedings. MSD Ireland’s chief executive Gerard Brennan says if Clonmel …
